BMY vs WRBY · P/E 17, rev $24.46B vs rev $478.0M
Bristol-Myers Squibb Company (BMY) versus Warby Parker Inc (WRBY) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Warby Parker Inc (WRBY) is a medical instruments & supplies company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported WRBY revenue for 2026-06-30 was $478.0M. Net income was $7.8M. Revenue was up 97.1% from 2026-03-31 to 2026-06-30. WRBY currently screens at market cap $2.70B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. WRBY currently screens at market cap $2.70B.
Not investment advice. Open the BMY and WRBY stock pages for the full models.
Not investment advice.